Fresenius Medical Care AG

Common Name
Fresenius Medical Care
Country
Germany
Sector
Healthcare
Industry
Medical Care Facilities
Employees
112,445
Ticker
FME
Exchange
XETRA
Description
Fresenius Medical Care AG & Co. KGaA is a leading global provider of products and services for individuals with renal diseases, specifically focusing on chronic kidney failure. This German-based healt...

Financial Statements of Fresenius Medical Care

Below are the financial statements of Fresenius Medical Care, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of EUR20242023
Assets
Cash and cash equivalents
1,180.19a
1,403.49a
Trade accounts and other receivables from unrelated parties
3,367.11a
3,471.21a
Accounts receivable from related parties
40.94a
165.3a
Inventories
2,067.92a
2,179.18a
Other current assets
671.84a
730.46a
Other current financial assets
433.74a
244.17a
Assets held for sale
161.01a
507.6a
Total current assets
7,922.74a
8,701.41a
Property, plant and equipment
3,646.13a
3,782.78a
Right-of-use assets
3,612.46a
3,671.24a
Intangible assets
1,370.08a
1,362.33a
Goodwill
15,170.65a
14,650.01a
Deferred taxes
229.51a
283.95a
Investment in equity method investees
620.83a
642.93a
Other non-current assets
198.33a
223.58a
Other non-current financial assets
795.86a
611.58a
Total non-current assets
25,643.84a
25,228.4a
Total assets
33,566.58a
33,929.81a
Liabilities
Accounts payable to unrelated parties
904.28a
762.07a
Accounts payable to related parties
80.04a
123.08a
Current provisions and other current liabilities
1,499.93a
1,617.43a
Other current financial liabilities
1,787.37a
1,675.56a
Short-term debt from unrelated parties
2.1a
456.9a
Current portion of long-term debt
575.28a
487.7a
Current portion of lease liabilities from unrelated parties
615.98a
593.03a
Current portion of lease liabilities from related parties
24.9a
23.93a
Income tax liabilities
142.65a
191.27a
Liabilities directly associated with assets held for sale
27.51a
180.62a
Total current liabilities
5,660.06a
6,111.59a
Long-term debt, less current portion
6,260.83a
6,959.86a
Lease liabilities from unrelated parties, less current portion
3,411.86a
3,419.34a
Lease liabilities from related parties, less current portion
87.96a
109.65a
Non-current provisions and other non-current liabilities
374.16a
332.81a
Other non-current financial liabilities
538.69a
715.66a
Pension liabilities
678.67a
664.33a
Income tax liabilities
76.95a
39.75a
Deferred taxes
708.89a
750.29a
Total non-current liabilities
12,138.01a
12,991.68a
Total liabilities
17,798.07a
19,103.27a
Shareholders’ equity
Ordinary shares
293.41a
293.41a
Additional paid-in capital
3,345.41a
3,380.33a
Retained earnings
11,266.29a
10,921.69a
Accumulated other comprehensive income (loss)
-328.55a
-975.17a
Total FME AG shareholders’ equity
14,576.56a
13,620.26a
Noncontrolling interests
1,191.95a
1,206.27a
Total equity
15,768.51a
14,826.54a
Total liabilities and equity
33,566.58a
33,929.81a

Verified Sources Behind Fresenius Medical Care’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fresenius Medical Care’s data sources below and access millions more through our Disclosure Search.

a. Fresenius Medical Care's Annual Report 2024
Trace every data point back to Fresenius Medical Care’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?